Terlivaz (terlipressin) is a medication that helps to improve kidney function in people with hepatorenal syndrome (HRS). It's the first FDA-approved medication for this condition. Terlivaz (terlipressin) is only available in the hospital, and is given as an intravenous (IV, or into the veins) injection by a trained healthcare provider. Terlivaz (terlipressin) can put you at risk for serious breathing problems, so your provider will monitor your oxygen level closely while you receive treatment.
Improving kidney function in people with hepatorenal syndrome (HRS) with acute (sudden) kidney failure
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.